510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K003809Substantially Equivalent

Rapid Drugs of Abuse Single and Multiple Test Panels

Rapid Diagnostics, Inc., Burlingame CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K003809 is the FDA 510(k) clearance record for RAPID DRUGS OF ABUSE SINGLE AND MULTIPLE TEST PANELS, a class II device, cleared for Rapid Diagnostics, Inc. on under FDA product code DKZ (Enzyme Immunoassay, Amphetamine). FDA records list 4 510(k) clearances for Rapid Diagnostics, Inc., from to . As of , FDA records show no recalls naming K003809.

Clearance record

Decision date
Received
(133 days to decision)
Product code
DKZ Enzyme Immunoassay, Amphetamine
Regulation
21 CFR 862.3100
Device class
Class II
Review panel
Clinical Toxicology
Applicant
Rapid Diagnostics, Inc. 1429 Rollins Rd., Burlingame CA
510(k) summary
Summary
Third party review
No

Clearances, product code DKZ

Trailing 12 months

FDA records hold no clearances under product code DKZ in the trailing twelve months.

FDA records show no clearances under product code DKZ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code DKZ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260